Department Obstetrics and Gynecology, “Dell'Angelo Hospital -Zelarino 30174, Mestre-Venezia, Italy
Interests: Obstetrics and gynecology; Cervical cancer screening; Gynecology Oncology
Dr. Vasilios Pergialiotis
1.First Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece; 2. Laboratory of Experimental Surgery and Surgical Research N.S Christeas, National and Kapodistrian University of Athens, Athens, Greece
Cervical cancer of the uterus is a neoplasia in which the scientific progress has produced an impressive reduction in the incidence and mortality.
This is particurlaly linked with several development in the knowledge of the natural history of the disease:
● The patogenetic role of HPV infection has been definivelly well established with a clear multistep process of development; ● The organized population based cervical cancer screening programmes at national and regional level have produced an increasing detection of dysplasic and early invasive lesions particularly in young women; ● Introduction of HPV- high risk test as primary screening test has produce an anticipation of the detection of the dysplasic lesions; ● More conservative treatments have been proposed for the screen-detected lesions with consequent respect of the anatomo-functional integrity of the uterine cervix; ● Recently some markers of progression may be identified aiming to select which lesion requires follow-up istead of immediate treatment; ● Vaccination agaist HPV has been introduced in many western countries with an expected further reduction in the incidence of the disease; ● The first cohorts of vaccinated girls have reached the age of screening programme and the consequance of this implies a substantial changes in the strategies of the screening programme in term of organization, test to adopt, frequancy and interpretation of the results.
The special issue of the journal will offer to the readers the highlights of the researches in the field presented by authors with recognized international experience and reporting, in some part, the actual position of the national group of cervical screening programmes in Italy.
Prof. Dr. Tiziano Maggino
Manuscript Submission Information
Manuscripts should be submitted online at https://ejgo.imrpress.combyregisteringandlogging into this website. Once you are registered,click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on theInstructions for Authorspage. European Journal of Gynaecological Oncology is an international peer-reviewed open access quarterly journal published by IMR Press.
Please visit theInstructions for Authorspage before submitting a manuscript. TheArticle Processing Charge (APC)for publication in thisopen accessjournal is $1250. We normally offer a discount greater than 30% (APC: $850) to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.
Type: Review Title: Trend of cone dimension and CIN extension: 30 years experience of a tertiary center Author: Mario Preti
Title: Up date on HPV-vaccines and cervical cancer incidence Author: V. Baldo (Padua)
Title: Trend of cone dimension and CIN extension: 30 years experience of a tertiary center Author: M. Zappa (Florence)
Title: The follow-up of women treated for CIN 2 or 3: synopsis of the recommendations from the italian cervical cancer rprevention multisocietal group Author: P. Giorgi Rossi (Reggio Emilia), P. Garutti (Ferrara) and Multisocietal Group
Title: Recommendation on HPV vaccination in women treated for CIN 2 or 3: systematic review and recommendation from the italian cervical cancer prevention multisocietal group Author: P. Giorgi Rossi (Reggio Emilia), P. Garutti (Ferrara) and Italian Multisocietal Group
Title: The methodological framework adopted by the italian cervical cancer prevention multisocietal group in the production of recommendation Author: P. Giorgi Rossi (Reggio Emilia) and Italian Multisocietal Group
Title: Follow-up instead of immediate treatment in patients with CIN 2 lesion: study of veneto region Author: M.Zorzi (Padua), A. Del Mistro (Padua) and al